Inventor · Wien, AT

Friedrich Scheiflinger

76Patents
10h-index
74Co-inventors
81Inventor score

Filing activity: Aug 26, 1991 → Jan 30, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US7033590B1 Factor IX/factor IXa activating antibodies and antibody derivatives Human Necessities 34 Expired
US5670367A Recombinant fowlpox virus Chemistry; Metallurgy 23 Expired
US6919311B2 Factor VII polypeptide having factor VII:C activity Human Necessities 23 Expired
US5445953A Direct molecular cloning of a modified poxvirus genome Chemistry; Metallurgy 20 Expired
US6926894B2 Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV Chemistry; Metallurgy 19 Expired
US6103244A Methods for generating immune responses employing modified vaccinia of fowlpox viruses Chemistry; Metallurgy 16 Expired
US8546096B2 Method for identifying a non-anticoagulant sulfated polysaccharide which enhances blood coagulation dependence on FXI Physics 14 Active
US7884075B2 Polymer-factor VIII-von Willebrand factor-conjugates Chemistry; Metallurgy 13 Active
US8450275B2 TFPI inhibitors and methods of use Physics 12 Active
US10800816B2 TFPI inhibitors and methods of use Physics 10 Active
US8466108B2 TFPI inhibitors and methods of use Emerging Cross-Sectional Technologies 10 Active
US10201586B2 TFPI inhibitors and methods of use Physics 10 Active
US7501117B2 Composition exhibiting a von Willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV Chemistry; Metallurgy 9 Expired
US8357779B2 Polymer-von Willebrand factor-conjugates Chemistry; Metallurgy 9 Active
US8835388B2 Polymer von Willebrand factor-conjugates Chemistry; Metallurgy 9 Active
US6265183A Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteins Chemistry; Metallurgy 9 Expired
US7575897B2 Highly phosphorylated and sulfated recombinant factor IX Chemistry; Metallurgy 6 Active
US9272021B2 Treatment of coagulation disease by administration of recombinant VWF Human Necessities 5 Active
US7279161B2 Factor IX/factor IXa activating antibodies and antibody derivatives Human Necessities 4 Expired
US8962563B2 TFPI inhibitors and methods of use Physics 3 Active
US9018167B2 TFPI inhibitors and methods of use Physics 3 Active
US9447147B2 Peptides and methods of use Chemistry; Metallurgy 2 Active
US7297336B2 Factor IXa specific antibodies displaying factor VIIIa like activity Human Necessities 2 Expired
US7544660B2 Factor VIII polypeptide having factor VIII:C activity Human Necessities 2 Expired
US10189888B2 Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A Chemistry; Metallurgy 2 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.